Indian Panel Nudges Eisai Towards Phase IV Compliance For Halaven

 
• By Anju Ghangurde
  
Compliance
EISAI SOUGHT A PHASE IV TRIAL WAIVER BUT APPEARS SET TO COMPLY WITH THE NORMS NOW
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from Product Reviews